VeriSeq PGS

The VeriSeq PGS Kit takes advantage of next-generation sequencing (NGS) technology to provide comprehensive, accurate screening of all 24 chromosomes for selection of embryos most likely to be euploid. Preimplantation genetic screening (PGS) results generated using VeriSeq PGS are comparable to those achieved with the widely used array-based 24sure technology. In addition, NGS offers the opportunity for improved assay workflow, higher throughput, and enhanced performance.

• Industry-leading data quality: More than 90% of the world’s sequencing data is generated by Illumina sequencing by synthesis (SBS) chemistry
• Fast, streamlined workflow: Sample to answer in approximately 12 hours
• High-throughput analysis: Screen up to 24 samples per run

Ultra-Low Input

NGS offers a highly sensitive method for screening embryos, requiring as little as 1 ng of DNA from a SurePlex DNA amplification reaction. DNA can be obtained from a blastomere biopsy, from a day 3 embryo, or from a trophectodermal (TE) biopsy from a blastocyst.

VeriSeq PGS Solution on the MiSeq System Data Sheet | PDF(< 1 MB)

VeriSeq PGS Kit - MiSeq System Product Information Sheet Product Information Sheet | PDF(< 1 MB)

Visit    Web Site...